Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow, MA; Hoffman, L; Schafer, A; Osorio, DS; Boué, DR; Rush, S; Wright, E; Lane, A; DeWire-Schottmiller, MD; Smolarek, T; et al.
Acta Neuropathologica Communications.
2020;
8.
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire, M; Fuller, C; Hummel, TR; Chow, LM L; Salloum, R; de Blank, P; Pater, L; Lawson, S; Zhu, X; Dexheimer, P; et al.
Journal of Neuro-Oncology.
2020;
149:511-522.
A phase I and pharmacokinetic study of oral dabrafenib in children and adolescent patients with recurrent or refractory BRAF V600 mutation–positive solid tumors.
Kieran, MW; Geoerger, B; Dunkel, IJ; Broniscer, A; Hargrave, D; Hingorani, P; Aerts, I; Bertozzi, A; Cohen, KJ; Hummel, TR; et al.
Clinical Cancer Research.
2019;
25:7294-7302.
Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2.
Agresta, L; Salloum, R; Hummel, TR; Ratner, N; Mangano, FT; Fuller, C; McMasters, RL; Pater, L; Jones, BV; Szabo, S; et al.
Pediatric Blood and Cancer.
2019;
66:e27520-e27520.
Pediatric intramedullary spinal cord tumor outcomes using the WeeFIM scale.
Noh, T; Vogt, MS; Pruitt, DW; Hummel, TR; Mangano, FT.
Child's Nervous System.
2018;
34:1753-1758.
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
Salloum, R; McConechy, MK; Mikael, LG; Fuller, C; Drissi, R; DeWire, M; Nikbakht, H; De Jay, N; Yang, X; Boue, D; et al.
Acta Neuropathologica Communications.
2017;
5.
A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
Dorris, K; Liu, C; Li, D; Hummel, TR; Wang, X; Perentesis, J; Kim, M; Fouladi, M.
Pediatric Blood and Cancer.
2017;
64.
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
Salloum, R; Hummel, TR; Kumar, SS; Dorris, K; Li, S; Lin, T; Daryani, VM; Stewart, CF; Miles, L; Poussaint, TY; et al.
Journal of Neuro-Oncology.
2016;
129:443-451.
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel, TR; Salloum, R; Drissi, R; Kumar, S; Sobo, M; Goldman, S; Pai, A; Leach, J; Lane, A; Pruitt, D; et al.
Journal of Neuro-Oncology.
2016;
127:53-61.